Close



Apr 2, 2024 07:00AM
Apr 2, 2024 05:36AM
Apr 2, 2024 02:00AM
Feb 19, 2024 07:10AM
Feb 19, 2024 02:00AM
Jan 29, 2024 07:00AM
Jan 29, 2024 06:00AM AstraZeneca (AZN) Reports Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Jan 29, 2024 02:00AM
Oct 24, 2023 07:00AM
Oct 24, 2023 05:46AM
Oct 16, 2023 07:00AM
Oct 16, 2023 06:16AM
Jul 28, 2023 07:05AM
Jun 12, 2023 07:00AM Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer
Jun 12, 2023 05:32AM
Jun 8, 2023 05:35PM
Jun 8, 2023 05:31PM
Dec 21, 2022 06:05AM
Dec 15, 2022 05:53AM
Nov 9, 2022 07:00AM
Nov 9, 2022 06:16AM AstraZeneca (AZN) Announces FDA AdCom Recommends PT027 as Rescue Treatment for Asthma
Aug 16, 2022 07:00AM
Aug 16, 2022 06:06AM
Aug 5, 2022 11:51AM
Jul 25, 2022 07:00AM
Jul 25, 2022 05:56AM
Jul 25, 2022 02:00AM
May 4, 2022 08:00AM Imfinzi Plus Chemotherapy Granted Priority Review in the US for Patients With Locally Advanced or Metastatic Biliary Tract Cancer Based on TOPAZ-1 Phase III Trial
May 4, 2022 05:58AM
Apr 25, 2022 08:00AM
Apr 25, 2022 05:34AM
Apr 19, 2022 07:00AM
Apr 19, 2022 05:54AM
Apr 19, 2022 02:00AM
Jan 18, 2022 05:20AM AstraZeneca's (AZN) ENHERTU Granted Priority Review in the US for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Jan 17, 2022 07:00AM
Jan 17, 2022 07:00AM
Jan 17, 2022 02:00AM
Dec 21, 2021 05:05AM
Nov 30, 2021 06:32AM
Nov 30, 2021 06:30AM
Nov 30, 2021 05:34AM AstraZeneca's (AZN) Lynparza Granted Priority Review by the FDA
Jul 8, 2021 07:00AM
Jul 8, 2021 05:03AM
Apr 30, 2021 09:28AM
Oct 28, 2020 07:20AM
Oct 28, 2020 07:00AM
Oct 20, 2020 08:01AM
Oct 14, 2020 07:08AM FibroGen (FGEN) to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week
Oct 14, 2020 07:00AM

12,341 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All